Pere-Joan Cardona i Iglèsias

Almirall Ltd. is an international pharmaceutical company based on innovation and committed to health, headquartered in Barcelona, Spain. In Almirall they research, develop, produce and market proprietary R&D medicines and those under licence with the aim of improving people's health and wellbeing. They devote big human and economic resources to constant research into new drugs and to obtaining effective and safe products against discomfort and disease.

Asociacion De Empresas Biotecnologicas operates as a Spanish biotechnology company. The private company is based in Madrid, Spain.

Aquilón Cyl SL develops vaccines and probiotics to combat swine diseases. It develops the findings and inventions of Spanish research, basically in the veterinary medicine field. The company was founded by Nistal Pedro Miguel Rubio in March, 2012 and is headquartered in Leon, Spain.

Immuni Therapeutics SL is a Spanish company that develops vaccines against COVID-19 and other viruses. The private company is based in Badalona, Spain. Immuni Therapeutics is promoted by Archivel Farma, the owner of the Ruti vaccine, which has yielded the rights for its development and commercialization to the new company. The Ruti vaccine is unique as it is based on the potentiation of the "trained innate immunity" in the patient, making it compatible with other vaccines and better adapted to the possible mutations of the virus or the arrival of new ones. Luis Antonio Ruiz-Avila has been the CEO of the company since 2020.

Leukos Biotech SL develops of new treatments for acute myeloid leukaemia and other haematological malignancies. The company was founded by Ruth Munoz Risueño in 2015 and is headquartered in Barcelona, Spain.

Kintsugi Therapeutics is a biomedical start-up based in Barcelona, Spain. The Spanish company focuses on developing innovative therapies for the treatment of liver conditions and other pathologies by targeting the regulation of endoplasmic reticulum stress. The company's lead candidate is a first-in-class endoplasmic reticulum stress inhibitor being developed for the treatment of non-alcoholic steatohepatitis (NASH). The company was founded by Carmen Herrero and Marc Cusachs, with Carmen Herrero serving as the CEO since incorporation.

Rob Surgical Systems SL designs and develops robotic systems for minimally invasive surgery. The company is based in Barcelona, Spain. The CEO of the Spanish company is Jaume Amat i Reira.